$2.42T
Total marketcap
$81.83B
Total volume
BTC 51.25%     ETH 14.64%
Dominance

Targeted Medical Pharma TRGM Stock

0.0001 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
322.99K USD
LOW - HIGH [24H]
0.0001 - 0.0001 USD
VOLUME [24H]
11.68K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Targeted Medical Pharma Price Chart

Targeted Medical Pharma TRGM Financial and Trading Overview

Targeted Medical Pharma stock price 0.0001 USD
Previous Close 0.0001 USD
Open 0.0001 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.0001 - 0.0001 USD
52 Week Range 0.0001 - 0.0006 USD
Volume 13.8K USD
Avg. Volume 219 USD
Market Cap 322.99K USD
Beta (5Y Monthly) -0.228521
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

TRGM Valuation Measures

Enterprise Value 5.19M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.06139339
Price/Book (mrq) N/A
Enterprise Value/Revenue 0.987
Enterprise Value/EBITDA -3.128

Trading Information

Targeted Medical Pharma Stock Price History

Beta (5Y Monthly) -0.228521
52-Week Change -66.66%
S&P500 52-Week Change 20.43%
52 Week High 0.0006 USD
52 Week Low 0.0001 USD
50-Day Moving Average 0.0001 USD
200-Day Moving Average 0.000255 USD

TRGM Share Statistics

Avg. Volume (3 month) 219 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 30.19M
Float 11.58M
Short Ratio N/A
% Held by Insiders 61.64%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2015
Most Recent Quarter (mrq) December 31, 2015
Next Fiscal Year End December 31, 2016

Profitability

Profit Margin -57.85%
Operating Margin (ttm) -35.93%
Gross Margin 60.16%
EBITDA Margin -31.54%

Management Effectiveness

Return on Assets (ttm) -47.95%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 5.26M USD
Revenue Per Share (ttm) 0.19 USD
Quarterly Revenue Growth (yoy) -9.00000000000000000000000000000000%
Gross Profit (ttm) 3.17M USD
EBITDA -1659785 USD
Net Income Avi to Common (ttm) -3043810 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 82.64K USD
Total Cash Per Share (mrq) 0.003 USD
Total Debt (mrq) 5.29M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.057
Book Value Per Share (mrq) -0.465

Cash Flow Statement

Operating Cash Flow (ttm) -1278617 USD
Levered Free Cash Flow (ttm) -174023 USD

Profile of Targeted Medical Pharma

Country United States
State CA
City Los Angeles
Address 2980 Beverly Glen Circle
ZIP 90077
Phone 310-474-9809
Website https://www.targetedmedicalpharma.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 30

Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy. The company also provides a proprietary billing process and supporting software (PDRx) that facilitates physician dispensing; provides inventory control; and assists regulatory reporting. In addition, it offers billing and collection services relating to its products on behalf of dispensing physician clients to private insurance and workers' compensation insurance. Targeted Medical Pharma, Inc. distributes its products through a network of distributors and an internal sales force that sells products directly to dispensing physician clients. The company was formerly known as Targeted Medical Foods and changed its name to Targeted Medical Pharma, Inc. in 2006. Targeted Medical Pharma, Inc. was founded in 1996 and is headquartered in Los Angeles, California.

Q&A For Targeted Medical Pharma Stock

What is a current TRGM stock price?

Targeted Medical Pharma TRGM stock price today per share is 0.0001 USD.

How to purchase Targeted Medical Pharma stock?

You can buy TRGM shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Targeted Medical Pharma?

The stock symbol or ticker of Targeted Medical Pharma is TRGM.

Which industry does the Targeted Medical Pharma company belong to?

The Targeted Medical Pharma industry is Drug Manufacturers-Specialty & Generic.

How many shares does Targeted Medical Pharma have in circulation?

The max supply of Targeted Medical Pharma shares is 3.23B.

What is Targeted Medical Pharma Price to Earnings Ratio (PE Ratio)?

Targeted Medical Pharma PE Ratio is now.

What was Targeted Medical Pharma earnings per share over the trailing 12 months (TTM)?

Targeted Medical Pharma EPS is 0 USD over the trailing 12 months.

Which sector does the Targeted Medical Pharma company belong to?

The Targeted Medical Pharma sector is Healthcare.